• Je něco špatně v tomto záznamu ?

Psychiatric manifestations in Wilson's disease: possibilities and difficulties for treatment

T. Litwin, P. Dusek, T. Szafrański, K. Dzieżyc, A. Członkowska, JK. Rybakowski,

. 2018 ; 8 (7) : 199-211. [pub] 20180306

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu časopisecké články, přehledy

Perzistentní odkaz   https://www.medvik.cz/link/bmc18034412

Wilson's disease (WD) is an inherited metabolic disorder related to disturbances of copper metabolism, and predominantly presents with liver and neuropsychiatric symptoms. In most cases it can be successfully treated with anti-copper agents, and both liver function and neuropsychiatric symptoms typically improve. Treatment guidelines for WD include recommendations for anti-copper treatment as well as for the treatment of liver failure symptoms. Recently, recommendations for treatment of the neurological symptoms of WD have also been proposed. Although most WD patients present with psychiatric symptoms at some stage of the disease, currently there are no guidelines for the treatment of the psychiatric manifestations. Treatment of the psychiatric symptoms of WD is often guided by general psychiatric experience, which typically glosses over the specificity of WD, and can result in severe neurological and/or hepatic complications. Here we review and discuss the possible treatments available for the mood disturbances, psychosis, behavioral and cognitive disorders that can occur in WD, as well as their efficacy.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc18034412
003      
CZ-PrNML
005      
20181012092742.0
007      
ta
008      
181008s2018 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1177/2045125318759461 $2 doi
035    __
$a (PubMed)29977520
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Litwin, Tomasz $u Second Department of Neurology, Institute of Psychiatry and Neurology, Sobieskiego 9, 02-957 Warsaw, Polandc.
245    10
$a Psychiatric manifestations in Wilson's disease: possibilities and difficulties for treatment / $c T. Litwin, P. Dusek, T. Szafrański, K. Dzieżyc, A. Członkowska, JK. Rybakowski,
520    9_
$a Wilson's disease (WD) is an inherited metabolic disorder related to disturbances of copper metabolism, and predominantly presents with liver and neuropsychiatric symptoms. In most cases it can be successfully treated with anti-copper agents, and both liver function and neuropsychiatric symptoms typically improve. Treatment guidelines for WD include recommendations for anti-copper treatment as well as for the treatment of liver failure symptoms. Recently, recommendations for treatment of the neurological symptoms of WD have also been proposed. Although most WD patients present with psychiatric symptoms at some stage of the disease, currently there are no guidelines for the treatment of the psychiatric manifestations. Treatment of the psychiatric symptoms of WD is often guided by general psychiatric experience, which typically glosses over the specificity of WD, and can result in severe neurological and/or hepatic complications. Here we review and discuss the possible treatments available for the mood disturbances, psychosis, behavioral and cognitive disorders that can occur in WD, as well as their efficacy.
655    _2
$a časopisecké články $7 D016428
655    _2
$a přehledy $7 D016454
700    1_
$a Dusek, Petr $u Department of Neurology and Centre of Clinical Neuroscience, First Faculty of Medicine and General University Hospital, Prague, Czech Republic.
700    1_
$a Szafrański, Tomasz $u Specialist Medical Practice Tomasz Szafrański, Warsaw, Poland.
700    1_
$a Dzieżyc, Karolina $u Second Department of Neurology, Institute Psychiatry and Neurology, Warsaw, Poland.
700    1_
$a Członkowska, Anna $u Second Department of Neurology, Institute Psychiatry and Neurology, Warsaw, Poland.
700    1_
$a Rybakowski, Janusz K $u Department of Adult Psychiatry, Poznan University of Medical Sciences, Poznan, Poland.
773    0_
$w MED00177177 $t Therapeutic advances in psychopharmacology $x 2045-1253 $g Roč. 8, č. 7 (2018), s. 199-211
856    41
$u https://pubmed.ncbi.nlm.nih.gov/29977520 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20181008 $b ABA008
991    __
$a 20181012093234 $b ABA008
999    __
$a ind $b bmc $g 1340530 $s 1031406
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2018 $b 8 $c 7 $d 199-211 $e 20180306 $i 2045-1253 $m Therapeutic advances in psychopharmacology $n Ther Adv Psychopharmacol $x MED00177177
LZP    __
$a Pubmed-20181008
Zpět

Najít záznam

Citační ukazatele

Možnosti archivace